Kirsch, F., Schramm, A., Schwarzkopf, L., Lutter, J. I., Szentes, B., Huber, M., & Leidl, R. (2019). Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: Results from the LQ-DMP study. Respir Res.
Citação norma ChicagoKirsch, Florian, Anja Schramm, Larissa Schwarzkopf, Johanna I. Lutter, Boglárka Szentes, Manuel Huber, and Reiner Leidl. "Direct and Indirect Costs of COPD Progression and Its Comorbidities in a Structured Disease Management Program: Results From the LQ-DMP Study." Respir Res 2019.
Citação norma MLAKirsch, Florian, et al. "Direct and Indirect Costs of COPD Progression and Its Comorbidities in a Structured Disease Management Program: Results From the LQ-DMP Study." Respir Res 2019.